Condition

Adult Acute Myeloid Leukemia With Del(5q)

ClinicalTrials.gov condition label

Clinical trials5

Recruiting0

Common interventions12

Lead sponsors shown5

Clinical trials

5 shown

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantNCT01558778 · 2012-05-01

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesNCT01273766 · 2011-01-01

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadNCT01159067 · 2010-07-01

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNCT00890747 · 2009-08-01

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerNCT00112593 · 1999-11-01

Common interventions

laboratory biomarker analysisOTHER3 deferasiroxDRUG2 cyclosporineDRUG1 enzyme-linked immunosorbent assayOTHER1 fludarabine phosphateDRUG1 management of therapy complicationsPROCEDURE1 musculoskeletal complications management/preventionPROCEDURE1 mycophenolate mofetilDRUG1 peripheral blood stem cell transplantationPROCEDURE1 pharmacological studyOTHER1 sunitinib malateDRUG1 total-body irradiationRADIATION1

Leading sponsors

City of Hope Medical Center1 Fred Hutchinson Cancer Center1 National Cancer Institute (NCI)1 Roswell Park Cancer Institute1 Wake Forest University Health Sciences1

Trial status mix

COMPLETED3

TERMINATED1

WITHDRAWN1

Phase mix

NA2

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.